Instances of a threatening superbug that scientists are calling the “phantom menace” are rising in the U.S., officials reported Thursday.

This particular strain of bacteria is a type of Carbapenem-resistant Enterobacteriaceae (CRE), which are dangerous because they typically are highly antibiotic-resistant and have steep mortality rates, the Centers for Disease Control and Prevention (CDC) said. According to the CDC, this CRE carries a plasmid with an enzyme that can break down certain antibiotics, which it can transfer to other bacteria in the body, the Washington Post explains.

But the “phantom menace” earned its name because it has gotten less attention than other CREs, since its antibiotic resistance is relatively lower than other strains, and because it can escape detection from scientists.

While there was only one case of the superbug in 2010, there have been 11 per year in 2013, 2014 and 2015. The CDC reported a total number of at least 43 patients in 19 states between June 2010 and August 2015.

“This is a tricky drug-resistant bacteria, and it isn’t easily found,” CDC Director Thomas Frieden told the Post. “What we’re seeing is an assault by the microbes on the last bastion of antibiotics.”

[The Washington Post]

Get our Health Newsletter. Sign up to receive the latest health and science news, plus answers to wellness questions and expert tips. Please enter a valid email address. Sign Up Now Check the box if you do not wish to receive promotional offers via email from TIME. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Thank you! For your security, we've sent a confirmation email to the address you entered. Click the link to confirm your subscription and begin receiving our newsletters. If you don't get the confirmation within 10 minutes, please check your spam folder.

Write to Julia Zorthian at julia.zorthian@time.com.